[go: up one dir, main page]

FI972660L - Piperazine-2,5-dione derivatives as multidrug resistance modulators - Google Patents

Piperazine-2,5-dione derivatives as multidrug resistance modulators Download PDF

Info

Publication number
FI972660L
FI972660L FI972660A FI972660A FI972660L FI 972660 L FI972660 L FI 972660L FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A FI 972660 L FI972660 L FI 972660L
Authority
FI
Finland
Prior art keywords
piperazine
multidrug resistance
dione derivatives
resistance modulators
modulators
Prior art date
Application number
FI972660A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI972660A7 (en
FI972660A0 (en
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of FI972660A0 publication Critical patent/FI972660A0/en
Publication of FI972660L publication Critical patent/FI972660L/en
Publication of FI972660A7 publication Critical patent/FI972660A7/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
FI972660A 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as multidrug resistance modulators a FI972660A7 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003027 WO1996020190A1 (en) 1994-12-23 1995-12-22 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance

Publications (3)

Publication Number Publication Date
FI972660A0 FI972660A0 (en) 1997-06-19
FI972660L true FI972660L (en) 1997-08-22
FI972660A7 FI972660A7 (en) 1997-08-22

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972660A FI972660A7 (en) 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as multidrug resistance modulators a

Country Status (19)

Country Link
EP (1) EP0799222A1 (en)
JP (1) JPH10511384A (en)
CN (1) CN1175253A (en)
AU (1) AU698828B2 (en)
BG (1) BG101602A (en)
BR (1) BR9510410A (en)
CA (1) CA2207500A1 (en)
CZ (1) CZ190097A3 (en)
FI (1) FI972660A7 (en)
GB (1) GB9426224D0 (en)
HU (1) HUT77943A (en)
IL (1) IL116525A0 (en)
NO (1) NO972937L (en)
NZ (1) NZ297847A (en)
PL (1) PL320916A1 (en)
SK (1) SK83697A3 (en)
TW (1) TW358094B (en)
WO (1) WO1996020190A1 (en)
ZA (1) ZA9510909B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
HUP0001531A3 (en) * 1996-10-18 2000-09-28 Xenova Ltd Slough Anthranilic acid derivatives as multi drug resistance modulators
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
AU761018B2 (en) 1998-10-08 2003-05-29 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)
BR0017067A (en) * 2000-01-18 2002-10-22 Nereus Pharmaceuticals Inc Cell division inhibitor, dehydrogenase, method for producing a cell division and compound inhibitor
CA2453050A1 (en) 2000-09-06 2002-03-14 A.P. Pharma, Inc. Degradable polyacetal polymers
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
ES2295695T3 (en) 2002-08-02 2008-04-16 Nereus Pharmaceuticals, Inc. DEHYDROPHENYLHYSINAS AND ITS ANALOGS AND THE SYNTHESIS OF DEHYDROPHENYLHYTHINES AND THEIR ANALOGS.
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (en) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 2,5-diketopiperazine derivative, as well as preparation method and application thereof in preparing control agent for resisting marine fouling organisms
JP6769982B2 (en) 2015-03-06 2020-10-14 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド How to treat cancer associated with RAS mutations
KR102623404B1 (en) 2015-03-06 2024-01-11 비욘드스프링 파마수티컬스, 인코포레이티드. How to Treat Brain Tumors
ES2910035T3 (en) 2015-07-13 2022-05-11 Beyondspring Pharmaceuticals Inc Plinabulin Compositions
CA3013467A1 (en) 2016-02-08 2017-08-17 Beyondspring Pharmaceuticals, Inc. Compositions containing tucaresol or its analogs
EP3463337A4 (en) 2016-06-06 2020-02-12 Beyondspring Pharmaceuticals, Inc. COMPOSITION AND METHOD FOR REDUCING NEUTROPENIA
CN110431135A (en) 2017-01-06 2019-11-08 大连万春布林医药有限公司 Tubulin binding compounds and therapeutic uses thereof
KR20190109479A (en) 2017-02-01 2019-09-25 비욘드스프링 파마수티컬스, 인코포레이티드. How to reduce neutropenia
SG11202006985TA (en) 2018-01-24 2020-08-28 Beyondspring Pharmaceuticals Inc Composition and method for reducing thrombocytopenia via the administration of plinabulin
WO2022216908A1 (en) 2021-04-09 2022-10-13 Beyondspring Pharmaceuticals, Inc. Therapeutic compositions and methods for treating tumors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2718830B2 (en) * 1992-07-10 1998-02-25 ラボラトワール、グラクソ、ソシエテ、アノニム Anilide derivative
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
NO972937D0 (en) 1997-06-23
EP0799222A1 (en) 1997-10-08
WO1996020190A1 (en) 1996-07-04
SK83697A3 (en) 1998-05-06
CN1175253A (en) 1998-03-04
ZA9510909B (en) 1996-08-30
NO972937L (en) 1997-06-23
AU4310096A (en) 1996-07-19
BG101602A (en) 1998-02-27
CA2207500A1 (en) 1996-07-04
PL320916A1 (en) 1997-11-10
NZ297847A (en) 1999-04-29
IL116525A0 (en) 1996-03-31
FI972660A7 (en) 1997-08-22
FI972660A0 (en) 1997-06-19
GB9426224D0 (en) 1995-02-22
AU698828B2 (en) 1998-11-05
BR9510410A (en) 1999-09-08
HUT77943A (en) 1998-12-28
JPH10511384A (en) 1998-11-04
TW358094B (en) 1999-05-11
CZ190097A3 (en) 1998-01-14

Similar Documents

Publication Publication Date Title
FI972660L (en) Piperazine-2,5-dione derivatives as multidrug resistance modulators
NO991563L (en) N-substituted azaheterocyclic compounds
TR199501528A1 (en) Pyrrole derivatives.
ATE231847T1 (en) SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALINE DERIVATIVES
MA24354A1 (en) SUBSTITUTED PYRROLES
MA24287A1 (en) SUBSTITUTED PYRROLES
DK0922050T3 (en) 3-descladinose-2,3-anhydroerythromycin derivatives
FI972661L (en) Piperazine-2,5-dione derivatives that modulate multidrug resistance
NO982124L (en) Condensed imidazole derivatives as multidrug resistance modulators
MA24288A1 (en) SUBSTITUTED PYRROLES
AU4310196A (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
ES1036800Y (en) FOLDING BICYCLE.
ES1033728Y (en) PERFECTED FOLDING BAG.
GB2310854B (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
ES1034386Y (en) PERFECTED FOLDING SHOE.
ES1034169Y (en) PERFECTED BAG.
ES1034154Y (en) PERFECTED FOLDER.
GB9815066D0 (en) Piperazine 2, 5-dione derivatives as modulators of multidrug resistance
ES1037001Y (en) PERFECTED FOLDER.
ES1037927Y (en) PERFECTED BAG.
ES1028279Y (en) PERFECTED BAG.
ES1027401Y (en) PERFECTED BAG.
ES1043496Y (en) PERFECTED FOLDER.
KR970054605U (en) Folding bike
ES1032008Y (en) PERFECTED BAG.